In Response to your questions about IEC 60601-1 related to US FDA Submissions. If you tested under an older version of a standard when you submitted and the device has not changed or has not had significant changes, refer to Guidance documents on 510(k) Changes for medical devices and for software (2 documents), then you don't have a requirement to retest to the most recent standard. Also, note if there have a been a lot of little changes you still may need a "Catch-up 510(k)" which is also covered in these Guidance documents mentioned above. But once you do a significant change or have a catch 510(k) you will need to test to the updated standards.
For Europe (under the EU MDD, AIMDD, & IVD) having manufactured a device is not the time that meets the 'Placing on the EU Market'. Refer to the document
located at this link for what the EU's interpretation of "Placing on the Market" means. one part of the text of this document says "The interpretation of these terms indicates that the mere termination of the manufacture is not sufficient for a product to be placed on the market. In addition, it must have entered into the distribution chain.", but that is not sufficient so please read the whole document as there are quite a few subtleties in it. So, I would roughly say when the device is at a location (like a warehouse or distribution point) where the device(s) have been sold to the organization purchasing them or similarly to that would be where the product needs to be located that you can have an older set of testing to be legally sold. So, I do not agree with your statement about Europe.
Hope this is helpful,
------------------------------
Leonard (Leo) Eisner, P.E.
The "IEC 60601 Guy"
Principal Consultant, Eisner Safety Consultants
Phone: (503) 244-6151
Mobile: (503) 709-8328
Email:
Leo@EisnerSafety.comWebsite:
www.EisnerSafety.com------------------------------
Original Message:
Sent: 01-Jun-2018 09:36
From: Anonymous Member
Subject: ISO 60601-X Standards
This message was posted by a user wishing to remain anonymous
Is it correct that a medical device that has a current 510(k) with an older version of a safety/emissions standard can continue selling the product in the US without testing to the current version? It is understood that any new submissions will require testing to the current standard.
I have found a reference that says that specific devices manufactured before a required implementation date may continue to be sold into Europe, and possibly other countries. Is that true? To clarify, if a device was manufactured on December 31, 2017 and the required date for the standard in Europe is Jan. 1, 2018 can that device be legally sold in Europe?